Literature DB >> 32735933

Synthesis of PLGA/chitosan/zeolites and PLGA/chitosan/metal organic frameworks nanofibers for targeted delivery of Paclitaxel toward prostate cancer cells death.

Babak Faraji Dizaji1, Mohammadreza Hasani Azerbaijan1, Niloofar Sheisi2, Pouya Goleij3, Tahereh Mirmajidi4, Faraz Chogan4, Mohammad Irani5, Fariborz Sharafian6.   

Abstract

In the present study, the various zeolites including hydrophilic Y zeolite, hydrophobic ZSM-5 zeolite and metal organic frameworks (MOFs) including MIL-101 and ZIF-8 were incorporated into the PLGA/chitosan nanofibers for controlled release of Paclitaxel anticancer drug against prostate cancer in vitro and in vivo. The synthesized nanoparticles and nanofibers were characterized using FTIR, XRD, SEM, BET and water contact angle analysis. The drug loading efficiency of nanofibers containing zeolites and MOFs indicated that the MOFs were more useful compared with zeolites for higher loading of Paclitaxel molecules. The Paclitaxel release behavior from nanofibers containing zeolites and MOFs were also examined. The MTT assay and DAPI staining analysis were used to determine the cytotoxicity and apoptosis effect of nanofibers containing Paclitaxel against LNCaP prostate cancer cell lines. The tumor inhibition rate in vivo was carried out to obtain the optimum nanofibrous formulation with maximum cell death percentage and tumor inhibition rate. The obtained results revealed the better activity of MOFs compared nanozeolites for higher loading of Paclitaxel drug into the nanoparticles and a more sustained release of drug from nanofibers containing MOFs.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Metal organic framework; PLGA/chitosan nanofibers; Paclitaxel; Prostate cancer; Zeolite

Mesh:

Substances:

Year:  2020        PMID: 32735933     DOI: 10.1016/j.ijbiomac.2020.07.228

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  6 in total

1.  Magnetite Nanoparticles Functionalized with Therapeutic Agents for Enhanced ENT Antimicrobial Properties.

Authors:  Mara Caciandone; Adelina-Gabriela Niculescu; Valentina Grumezescu; Alexandra Cătălina Bîrcă; Ionuț Cosmin Ghica; Bogdan Ștefan Vasile; Ovidiu Oprea; Ionela Cristina Nica; Miruna Silvia Stan; Alina Maria Holban; Alexandru Mihai Grumezescu; Ion Anghel; Alina Georgiana Anghel
Journal:  Antibiotics (Basel)       Date:  2022-05-05

2.  PVA/κ-carrageenan/Au/camptothecin/pegylated-polyurethane/paclitaxel nanofibers against lung cancer treatment.

Authors:  Mohammad Irani; Sina Mohammadrezaei Nodeh
Journal:  RSC Adv       Date:  2022-06-01       Impact factor: 4.036

3.  Bioactive Ibuprofen-Loaded PLGA Coatings for Multifunctional Surface Modification of Medical Devices.

Authors:  Oana Gherasim; Gianina Popescu-Pelin; Paula Florian; Madalina Icriverzi; Anca Roseanu; Valentina Mitran; Anisoara Cimpean; Gabriel Socol
Journal:  Polymers (Basel)       Date:  2021-04-27       Impact factor: 4.329

Review 4.  Advancements in Fabrication and Application of Chitosan Composites in Implants and Dentistry: A Review.

Authors:  Fariborz Sharifianjazi; Samad Khaksar; Amirhossein Esmaeilkhanian; Leila Bazli; Sara Eskandarinezhad; Peyman Salahshour; Farnaz Sadeghi; Sadegh Rostamnia; Seyed Mohammad Vahdat
Journal:  Biomolecules       Date:  2022-01-18

Review 5.  Molecular Landscape of LncRNAs in Prostate Cancer: A focus on pathways and therapeutic targets for intervention.

Authors:  Sepideh Mirzaei; Mahshid Deldar Abad Paskeh; Elena Okina; Mohammad Hossein Gholami; Kiavash Hushmandi; Mehrdad Hashemi; Azuma Kalu; Ali Zarrabi; Noushin Nabavi; Navid Rabiee; Esmaeel Sharifi; Hassan Karimi-Maleh; Milad Ashrafizadeh; Alan Prem Kumar; Yuzhuo Wang
Journal:  J Exp Clin Cancer Res       Date:  2022-07-01

6.  Compound Capecitabine Colon-Targeted Microparticle Prepared by Coaxial Electrospray for Treatment of Colon Tumors.

Authors:  Ruiqi Chen; Ruidong Zhai; Chao Wang; Shulong Liang; Jing Wang; Zhepeng Liu; Wenlin Li
Journal:  Molecules       Date:  2022-09-03       Impact factor: 4.927

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.